IRVINE, Calif., Oct. 16, 2024 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announced today that CEO Josh Riggs is scheduled to present at the 17th annual Main Event, hosted by LD Micro, on Tuesday, October 29th in Los Angeles. Oncocyte management will also be available for one-on-one meetings with investors. To schedule … Continue reading “Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles”
Breaking News
Breaking News
SKYX Announces a Collaboration with Wayfair for its Advanced and Smart Plug & Play Lighting for Retail and Professional Segments including Designers and Architects
SKYX will Offer a Variety of its Advanced and Smart Plug & Play Lighting and…
October 16, 2024
Breaking News
Join the Biofuels Brazil Forum 2024!
Biofuels Brazil Forum 2024 Join the Biofuels Brazil Forum 2024! New York, October 15, 2024…
October 16, 2024
Breaking News
The 10th World Battery & Energy Storage Industry Expo (WBE 2025)
The 10th World Battery & Energy Storage Industry Expo (WBE 2025) Date: August 8th-10th, 2025…
October 16, 2024
Breaking News
4VITAHEALTH Launches Groundbreaking Mental Health Supplements
Tucson, Arizona, October 15, 2024 – PRISM MediaWire – 4VITAHEALTH, a pioneering mental health and…
October 15, 2024
Breaking News
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
Vendaje AC to launch across MAC regions nationwide through Venture Medical, the Company’s exclusive sales…
October 15, 2024
Breaking News
Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance
Q2 Sequential Revenue Growth Meets Quarterly Guidance of 2%-5% Record Equipment and Service Backlog of…
October 15, 2024
Breaking News
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
KLTO strengthens team with industry veteran and is poised to accelerate the development of its…
October 15, 2024
Breaking News
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
Patent application covers key technology innovations for delivering therapeutic agents Proprietary technology enables precise delivery…
October 15, 2024
Breaking News
SPZI: JP 3E Holdings, Inc. Accelerates Growth with Major Corporate Milestones Toward Uplisting
NEW YORK, October 14, 2024 – PRISM MediaWire – JP 3E Holdings, Inc. (OTC: SPZI),…
October 14, 2024
Breaking News
In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference
New York, New York, October 10, 2024 – PRISM MediaWire – PRISM MediaWire – Mental…
October 10, 2024
Breaking News
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
PITTSBURGH, Oct. 09, 2024 – PRISM MediaWire – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or…
October 9, 2024
Breaking News
SKYX Provides Corporate Update, including Significant Insider Buying
MIAMI, Oct. 09, 2024 – PRISM MediaWire – SKYX (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), a…
October 9, 2024
Breaking News
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial
Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast…
October 8, 2024